Elevance Health SG&A Expenses 2010-2025 | ELV
Elevance Health annual/quarterly sg&a expenses history and growth rate from 2010 to 2025. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
- Elevance Health sg&a expenses for the quarter ending March 31, 2025 were $0M, a 0% increase year-over-year.
- Elevance Health sg&a expenses for the twelve months ending March 31, 2025 were $0M, a 0% increase year-over-year.
- Elevance Health annual sg&a expenses for 2024 were $0B, a 0% decline from 2023.
- Elevance Health annual sg&a expenses for 2023 were $0B, a 0% decline from 2022.
- Elevance Health annual sg&a expenses for 2022 were $0B, a 0% decline from 2021.
| Elevance Health Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $0 |
| 2021 | $0 |
| 2020 | $17,450 |
| 2019 | $13,364 |
| 2018 | $14,020 |
| 2017 | $12,650 |
| 2016 | $12,559 |
| 2015 | $12,535 |
| 2014 | $11,748 |
| 2013 | $9,953 |
| 2012 | $8,681 |
| 2011 | $8,436 |
| 2010 | $8,733 |
| 2009 | $9,019 |
| Elevance Health Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2025-03-31 | |
| 2024-12-31 | |
| 2024-09-30 | |
| 2024-06-30 | |
| 2024-03-31 | |
| 2023-12-31 | |
| 2023-09-30 | |
| 2023-06-30 | |
| 2023-03-31 | |
| 2022-12-31 | |
| 2022-09-30 | |
| 2022-06-30 | |
| 2022-03-31 | |
| 2021-12-31 | |
| 2021-09-30 | $3,946 |
| 2021-06-30 | $3,821 |
| 2021-03-31 | $3,925 |
| 2020-12-31 | $4,318 |
| 2020-09-30 | $5,305 |
| 2020-06-30 | $4,046 |
| 2020-03-31 | $3,781 |
| 2019-12-31 | $3,502 |
| 2019-09-30 | $3,418 |
| 2019-06-30 | $3,278 |
| 2019-03-31 | $3,166 |
| 2018-12-31 | $3,618 |
| 2018-09-30 | $3,546 |
| 2018-06-30 | $3,428 |
| 2018-03-31 | $3,428 |
| 2017-12-31 | $3,394 |
| 2017-09-30 | $3,011 |
| 2017-06-30 | $3,054 |
| 2017-03-31 | $3,191 |
| 2016-12-31 | $3,265 |
| 2016-09-30 | $3,125 |
| 2016-06-30 | $2,969 |
| 2016-03-31 | $3,200 |
| 2015-12-31 | $3,268 |
| 2015-09-30 | $3,080 |
| 2015-06-30 | $3,041 |
| 2015-03-31 | $3,145 |
| 2014-12-31 | $3,033 |
| 2014-09-30 | $2,968 |
| 2014-06-30 | $2,886 |
| 2014-03-31 | $2,862 |
| 2013-12-31 | $2,646 |
| 2013-09-30 | $2,543 |
| 2013-06-30 | $2,436 |
| 2013-03-31 | $2,329 |
| 2012-12-31 | $2,354 |
| 2012-09-30 | $2,079 |
| 2012-06-30 | $2,082 |
| 2012-03-31 | $2,166 |
| 2011-12-31 | $2,228 |
| 2011-09-30 | $2,120 |
| 2011-06-30 | $2,011 |
| 2011-03-31 | $2,077 |
| 2010-12-31 | $2,341 |
| 2010-09-30 | $2,063 |
| 2010-06-30 | $2,155 |
| 2010-03-31 | $2,174 |
| 2009-12-31 | $2,324 |
| 2009-09-30 | $2,260 |
| 2009-06-30 | $2,206 |
| 2009-03-31 | $2,229 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $94.057B | $177.011B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $141.273B | 26.50 |
| CVS Health (CVS) | United States | $84.883B | 10.55 |
| Cencora (COR) | United States | $56.618B | 20.55 |
| Natera (NTRA) | United States | $21.276B | 0.00 |
| DiDi Global (DIDIY) | China | $19.908B | 30.21 |
| BioMerieux (BMXMF) | France | $15.658B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.897B | 0.00 |
| Solventum (SOLV) | United States | $11.572B | 10.79 |
| ICON (ICLR) | Ireland | $11.550B | 10.74 |
| CochLear (CHEOY) | Australia | $11.542B | 0.00 |
| Revvity (RVTY) | United States | $11.153B | 18.83 |
| Doximity (DOCS) | United States | $11.088B | 57.66 |
| Viatris (VTRS) | United States | $10.187B | 3.24 |
| Medpace Holdings (MEDP) | United States | $8.637B | 22.94 |
| Avantor (AVTR) | United States | $8.606B | 12.51 |
| Sonic Healthcare (SKHHY) | Australia | $8.191B | 0.00 |
| HealthEquity (HQY) | United States | $7.908B | 38.90 |
| Charles River Laboratories (CRL) | United States | $5.866B | 11.57 |
| Amplifon S.p.A (AMFPF) | Italy | $4.285B | 22.62 |
| Bausch + Lomb (BLCO) | Canada | $4.018B | 23.69 |
| BrightSpring Health Services (BTSG) | United States | $3.685B | 34.11 |
| Sotera Health (SHC) | United States | $3.667B | 20.84 |
| Alignment Healthcare (ALHC) | United States | $3.063B | 0.00 |
| Surgery Partners (SGRY) | United States | $3.009B | 34.51 |
| Concentras Parent (CON) | United States | $2.767B | 14.39 |
| Organon (OGN) | United States | $2.267B | 2.41 |
| Progyny (PGNY) | United States | $2.005B | 44.15 |
| Ardent Health Partners (ARDT) | United States | $1.880B | 0.00 |
| Premier (PINC) | United States | $1.873B | 11.99 |
| GeneDx Holdings (WGS) | United States | $1.857B | 72.70 |
| GoodRx Holdings (GDRX) | United States | $1.799B | 39.08 |
| Agilon Health (AGL) | United States | $1.702B | 0.00 |
| PACS (PACS) | United States | $1.536B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.254B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.111B | 9.32 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.967B | 0.00 | |
| CareDx (CDNA) | United States | $0.845B | 13.19 |
| AMN Healthcare Services Inc (AMN) | United States | $0.759B | 6.01 |
| Embecta (EMBC) | United States | $0.724B | 4.96 |
| Nutex Health (NUTX) | United States | $0.720B | 14.10 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.516B | 13.67 |
| Sonida Senior Living (SNDA) | United States | $0.447B | 0.00 |
| Enhabit (EHAB) | United States | $0.404B | 37.95 |
| InnovAge Holding (INNV) | United States | $0.391B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.375B | 0.00 |
| LifeMD (LFMD) | United States | $0.332B | 0.00 |
| SBC Medicals (SBC) | United States | $0.320B | 0.00 |
| DocGo (DCGO) | United States | $0.240B | 9.79 |
| Oncology Institute (TOI) | United States | $0.200B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.186B | 0.00 |
| Beauty Health (SKIN) | United States | $0.133B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.105B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.090B | 0.00 |
| So-Young (SY) | China | $0.085B | 0.00 |
| OncoCyte (OCX) | United States | $0.084B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.078B | 0.00 |
| Biodesix (BDSX) | United States | $0.069B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.025B | 0.00 |
| ModivCare (MODV) | United States | $0.020B | 7.05 |
| KindlyMD (KDLY) | United States | $0.016B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |